TWST Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own TWST shares is 360, representing 110.12% of the company's common stock.

CREDIT SUISSE AG/, in the last quarter, reduced its stake in TWST by -0.2% restricting it's holding to 1.42 million shares of worth nearly $48.74M. DIMENSIONAL FUND ADVISORS LP also lessened -0.92% of the TWST shares from its portfolio, reducing its holding to 1.26 million shares of worth $43.09M. VOLORIDGE INVESTMENT MANAGEMENT, LLC also shunned TWST shares holding by -7.59% last quarter which brought its holding to 711.7 thousand shares worth $24.42M.

As per its latest 13F filing, CASTLEARK MANAGEMENT LLC increased its stake in TWST by 11.79% in the last quarter. The institutional holder raised its holding to 146.63 thousand shares having worth more than $5.03M. BAILLIE GIFFORD & CO also added 12.13% more shares of TWST to its portfolio, raising its holding to 1.23 million shares of worth $42.12M. AMERICAN CENTURY COMPANIES INC also increased its TWST shares holding by 1,157.04% which brought its holding to 782.12 thousand shares worth $26.83M.

The insider with the most stakes in TWST is Leproust Emily M. , Chief Executive Officer at the company. Additionally, TWST stock is highly held by See Remark Banyai William and President and COO Finn Patrick John among others.

Company executives, directors, and other insiders own 1.94% percent of Twist Bioscience Corporation's stock. Within the last six months, there have been 48 transaction(s) in which TWST insiders have sold stock, totaling 124.22K shares. Insiders that have sold shares include FINN PATRICK JOHN, LAPONIS ADAM, and CHESS ROBERT.

There have been 0 transaction(s) during the past 6-months in which Twist Bioscience Corporation insiders have bought stock, totalling 0 shares

Around 9.48M Twist Bioscience Corporation shares are held by insiders, which represents about 1.94% of TWST stock.

TWST Chief Executive Officer, Leproust Emily M. holds the largest portfolio of the company's shares. TWST shares owned by Leproust total nearly 672.52 thousand.

CASTLEARK MANAGEMENT LLC is the largest institutional owner in TWST which holds 146.63 thousand shares worth $5.03M or 0.25% of the total TWST shares outstanding followed by CREDIT SUISSE AG/ with ownership of 1.42 million shares representing 2.47% of the TWST ownership. DIMENSIONAL FUND ADVISORS LP is the third largest stakeholder with 1.26 million shares or 2.18% of the ownership worth more than $43.09M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the TWST is concerned, it is a stock which is optionable.

Number of TWST shares short is 9.02M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 59.58M shares of TWST are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, TWST has 57.57M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for TWST is 15.97.